Professional Summary
Professional Overview
Max Meehan is an experienced corporate development professional with a strong background in the pharmaceutical and life sciences industries. As the Director of Corporate Development at Windgap Medical, Inc., he leverages his expertise in strategic planning, mergers and acquisitions, and business development to drive the company's growth initiatives.
Experience Summary
Current Role
In his current role as Director of Corporate Development at Windgap Medical, Inc., Max is responsible for evaluating and executing strategic partnership opportunities, identifying potential acquisition targets, and leading cross-functional teams to evaluate and integrate new businesses. He plays a key role in shaping the company's long-term growth strategy and positioning Windgap as a leader in the drug delivery space.
Career Progression
Prior to joining Windgap, Max served as the Chief of Staff to the CEO at Kindeva Drug Delivery, where he provided strategic counsel and operational support to drive the company's transformation and expansion. Before that, he was an Associate at Altaris Capital Partners, a leading healthcare-focused private equity firm, where he evaluated and executed investment opportunities across the pharmaceutical and medical device sectors.
Earlier in his career, Max was an Associate Consultant at Bain & Company, where he advised clients on a range of strategic and operational initiatives. He began his professional journey as a Medicaid Waiver Consultant at Lawrence General Hospital, where he helped the organization navigate the complex regulatory landscape and optimize patient access to healthcare services.
Academic Background
Max holds a Bachelor of Arts degree in Economics from Harvard University, where he graduated cum laude.
Areas of Expertise
- Corporate strategy and strategic planning
- Mergers and acquisitions
- Business development and partnership management
- Financial analysis and modeling
- Cross-functional collaboration and project management
Professional Impact
Throughout his career, Max has demonstrated a track record of driving tangible results for his employers. At Kindeva Drug Delivery, he played a pivotal role in the successful integration of a $1.2 billion acquisition, ensuring a smooth transition and the realization of synergies. At Altaris Capital Partners, he was instrumental in sourcing and evaluating several high-profile investment opportunities, contributing to the firm's strong investment performance.
Conclusion
With his extensive experience in the pharmaceutical and life sciences industries, coupled with his strategic acumen and operational expertise, Max Meehan is well-positioned to continue driving growth and innovation at Windgap Medical, Inc. He is a versatile, results-oriented professional committed to creating value for his clients and stakeholders.
